Two New Genetic Variants Discovered in Black South African Women with Breast Cancer

Introduction:

Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. While significant progress has been made in understanding its genetic basis, much of this research has focused on populations of European descent, leaving a critical gap in knowledge about breast cancer genetics in African populations. A recent groundbreaking study has addressed this disparity by identifying two genetic variants strongly associated with breast cancer risk in Black South African women. This discovery not only sheds light on the genetic underpinnings of the disease in underrepresented groups but also opens new avenues for personalized diagnostics and treatment.

### The Need for Inclusive Genetic Research

Historically, global cancer genetics research has largely excluded African populations. As a result, the risk assessment tools, treatments, and screening protocols derived from such studies may not be fully effective or accurate for people of African ancestry. Africa, particularly sub-Saharan Africa, harbors the greatest genetic diversity of any region in the world, yet it remains one of the least studied in terms of genetic disease risk.

This disparity has real consequences. In South Africa, Black women are often diagnosed with breast cancer at younger ages and at more advanced stages than their white counterparts. They also tend to present with more aggressive subtypes, such as triple-negative breast cancer, which are harder to treat. Until now, the genetic factors driving these patterns have been poorly understood.

### The Study and Its Findings

A team of South African and international researchers conducted a genome-wide association study (GWAS) involving thousands of Black South African women, including both breast cancer patients and healthy controls. Using high-throughput genotyping technology and rigorous statistical analysis, the researchers screened millions of genetic markers across the genome to identify variants that differ significantly between the two groups.

The study identified two specific genetic variants that are significantly associated with an increased risk of breast cancer in Black South African women. These variants, located on chromosomes 6 and 11, appear to influence gene regulation in pathways related to cell growth and DNA repair—processes that are crucial to cancer development.

One of the variants was found near a gene involved in the regulation of estrogen receptor signaling, which plays a key role in the development of hormone-sensitive breast cancers. The second variant appears to affect a gene associated with the cell cycle and genomic stability, suggesting a potential role in more aggressive tumor types.

### Implications for Personalized Medicine

The discovery of these two variants represents a major step forward in understanding breast cancer in African populations. These findings could eventually be used to develop genetic screening tools specifically tailored to South African women, allowing for earlier detection and more targeted interventions.

For instance, women carrying these high-risk variants might benefit from more frequent screenings or preventive therapies. Genetic counselors could use this information to assess family risk and guide decision-making around treatment and surveillance. Moreover, these discoveries lay the foundation for more inclusive precision medicine, ensuring that advances in oncology benefit all populations—not just those who have historically been the focus of research.

### Addressing Health Inequity

This research also highlights the importance of addressing long-standing health inequities. The underrepresentation of African populations in genomic studies not only limits our scientific understanding but also perpetuates disparities in healthcare outcomes. By investing in African-led research and infrastructure, and by including African genomes in international studies, the scientific community can help bridge this gap.

South Africa is uniquely positioned to lead such efforts, given its diverse population and growing research capacity. This study is a testament to the value of collaborative, inclusive research that centers the health needs of local communities.

### Future Directions

While the discovery of these two variants is a major breakthrough, it is just the beginning. The researchers note that breast cancer is a complex disease influenced by multiple genetic and environmental factors. Additional studies with larger sample sizes are needed to validate these findings and identify other risk loci specific to African populations.

Furthermore, functional studies are required to understand exactly how these variants contribute to cancer risk at the molecular level. Integrating genomic data with clinical outcomes, lifestyle information, and environmental exposures will provide a more complete picture of breast cancer risk and prog

END

Thanks for reading. please like and subscribe